Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Phys Chem B ; 126(33): 6171-6179, 2022 08 25.
Artigo em Inglês | MEDLINE | ID: mdl-35948046

RESUMO

The rate at which a Brownian particle confined in a closed space escapes from the space by passing through a narrow passage is called the escape rate. The escape rate is relevant to many diffusion limited processes in polymer and colloidal systems, such as colloidal aggregation, polymerization reaction, polymer translocation through a membrane, etc. Here, we propose a variational principle to calculate the escape rate of complex molecules doing Brownian motion in a multi-dimensional phase space. We propose a regional minimization method in which we divide the whole phase space into regions, conduct the minimization for each region, and combine the results to get the minimum in the entire space. As an example, we discuss (1) the escape rate of a point particle that escapes from a confinement passing through a long corridor and (2) the escape rate of a rod-like particle that escapes through a small hole made in the wall of the confinement.


Assuntos
Polímeros , Difusão , Movimento (Física)
2.
Proc Math Phys Eng Sci ; 476(2241): 20200001, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33071566

RESUMO

We develop a mathematical model for the sliding of a gel sheet adhered to a moving substrate. The sliding takes place by the motion of detached region between the gel sheet and the substrates, i.e. the propagation of a Schallamach wave. Efficient numerical methods are developed to solve the problem. Numerical examples illustrate that the model can describe the Schallamach wave and are consistent with the existing experiments qualitatively.

3.
FASEB J ; 33(11): 12800-12811, 2019 11.
Artigo em Inglês | MEDLINE | ID: mdl-31469601

RESUMO

The protein kinase mechanistic target of rapamycin (mTOR) performs diverse cellular functions through 2 distinct multiprotein complexes, mTOR complex (mTORC)1 and 2. Numerous studies using rapamycin, an mTORC1 inhibitor, have implicated a role for mTORC1 in several types of heart disease. People with diabetes are more susceptible to heart failure. mTORC1 activity is increased in the diabetic heart, but its functional significance remains controversial. To investigate the role of mTORC1 in the diabetic heart, we crossed OVE26 type 1 diabetic mice with transgenic mice expressing a constitutively active mTOR (mTORca) or kinase-dead mTOR (mTORkd) in the heart. The expression of mTORca or mTORkd affected only mTORC1 but not mTORC2 activities, with corresponding changes in the activities of autophagy, a cellular degradation pathway negatively regulated by mTORC1. Diabetic cardiac damage in OVE26 mice was dramatically reduced by mTORca but exacerbated by mTORkd expression as assessed by changes in cardiac function, oxidative stress, and myocyte apoptosis. These findings demonstrated that the enhanced mTORC1 signaling in the OVE26 diabetic heart was an adaptive response that limited cardiac dysfunction, suggesting that manipulations that enhance mTORC1 activity may reduce diabetic cardiac injury, in sharp contrast to the results previously obtained with rapamycin.-Xu, X., Kobayashi, S., Timm, D., Huang, Y., Zhao, F., Shou, W., Liang, Q. Enhanced mTOR complex 1 signaling attenuates diabetic cardiac injury in OVE26 mice.


Assuntos
Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Cardiomiopatias Diabéticas/metabolismo , Alvo Mecanístico do Complexo 1 de Rapamicina/metabolismo , Alvo Mecanístico do Complexo 2 de Rapamicina/metabolismo , Transdução de Sinais , Animais , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/patologia , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/patologia , Cardiomiopatias Diabéticas/genética , Cardiomiopatias Diabéticas/patologia , Alvo Mecanístico do Complexo 1 de Rapamicina/genética , Alvo Mecanístico do Complexo 2 de Rapamicina/genética , Camundongos , Camundongos Transgênicos
4.
Phys Rev E ; 99(6-1): 063303, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31330684

RESUMO

In 1931, Onsager proposed a variational principle which has become the base of many kinetic equations for nonequilibrium systems. We have been showing that this principle is useful in obtaining approximate solutions for the kinetic equations, but our previous method has a weakness that it can be justified, strictly speaking, only for small incremental time. Here we propose an improved method which does not have this drawback. The improved method utilizes the integral proposed by Onsager and Machlup in 1953, and can tell us which of the approximate solutions is the best solution without knowing the exact solution. The improved method has an advantage that it allows us to determine the steady state in nonequilibrium system by a variational calculus. We demonstrate this using three examples, (a) simple diffusion problem, (b) capillary problem in a tube with corners, and (c) free boundary problem in liquid coating, for which the kinetic equations are written in second or fourth-order partial differential equations.

5.
Gene ; 619: 71-75, 2017 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-26877226

RESUMO

Thalassemia is one of the most common hereditary blood disorders. Epidemiological data regarding the occurrence and distribution of thalassemia is important for designing appropriate prevention strategies. The objective of this study was to update and reveal the prevalence of thalassemia and mutation spectrum in the Baise region of southern China. We screened 47,500 individuals from Baise region by hematological and genetic analysis. Totally, 11,432 (24.07%) subjects were diagnosed as being carriers and patients of thalassemia, including 7290 (15.35%) subjects with α-thalassemia, 3152 (6.64%) subjects with ß-thalassemia and 990 (2.08%) subjects with both α-thalassemia and ß-thalassemia. Ten α-thalassemia mutations and 31 genotypes were identified in the α-thalassemia carriers and patients. Meanwhile, 13 ß-thalassemia mutations and 26 genotypes were characterized in the ß-thalassemia carriers and patients. Furthermore, the true prevalence of nondeletional mutations and Thailand type (-THAI) deletion mutation were first reported in this study. In addition, three cases of αα/ααα3.7, five cases of HKαα/αα and two rare ß-globin mutations, -86 (G>C) and CD 121 (G>T) were first identified in the Chinese Zhuang ethnic populations. Our data indicated that there was great heterogeneity and extensive spectrum of thalassemias in the Baise populations. The findings will be useful for genetic counseling and prevention of severe thalassemia in this region.


Assuntos
Frequência do Gene , Hemoglobinas Anormais/genética , Talassemia alfa/genética , Talassemia beta/genética , China , Humanos , Mutação , Prevalência , Talassemia alfa/epidemiologia , Talassemia alfa/etnologia , Talassemia beta/epidemiologia , Talassemia beta/etnologia
6.
Artigo em Inglês | MEDLINE | ID: mdl-25215823

RESUMO

We study the macroscopic behavior of two-phase flow in porous media from a phase-field model. A dissipation law is first derived from the phase-field model by homogenization. For simple channel geometry in pore scale, the scaling relation of the averaged dissipation rate with the velocity of the two-phase flow can be explicitly obtained from the model which then gives the force-velocity relation. It is shown that, for the homogeneous channel surface, Dacry's law is still valid with a significantly modified permeability including the contribution from the contact line slip. For the chemically patterned surfaces, the dissipation rate has a non-Darcy linear scaling with the velocity, which is related to a depinning force for the patterned surface. Our result offers a theoretical understanding on the prior observation of non-Darcy behavior for the multiphase flow in either simulations or experiments.


Assuntos
Modelos Teóricos , Movimento (Física) , Permeabilidade , Porosidade
7.
J Biol Chem ; 288(25): 18077-92, 2013 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-23658055

RESUMO

Cardiac autophagy is inhibited in type 1 diabetes. However, it remains unknown if the reduced autophagy contributes to the pathogenesis of diabetic cardiomyopathy. We addressed this question using mouse models with gain- and loss-of-autophagy. Autophagic flux was inhibited in diabetic hearts when measured at multiple time points after diabetes induction by streptozotocin as assessed by protein levels of microtubule-associated protein light chain 3 form 2 (LC3-II) or GFP-LC3 puncta in the absence and presence of the lysosome inhibitor bafilomycin A1. Autophagy in diabetic hearts was further reduced in beclin 1- or Atg16-deficient mice but was restored partially or completely by overexpression of beclin 1 to different levels. Surprisingly, diabetes-induced cardiac damage was substantially attenuated in beclin 1- and Atg16-deficient mice as shown by improved cardiac function as well as reduced levels of oxidative stress, interstitial fibrosis, and myocyte apoptosis. In contrast, diabetic cardiac damage was dose-dependently exacerbated by beclin 1 overexpression. The cardioprotective effects of autophagy deficiency were reproduced in OVE26 diabetic mice. These effects were associated with partially restored mitophagy and increased expression and mitochondrial localization of Rab9, an essential regulator of a non-canonical alternative autophagic pathway. Together, these findings demonstrate that the diminished autophagy is an adaptive response that limits cardiac dysfunction in type 1 diabetes, presumably through up-regulation of alternative autophagy and mitophagy.


Assuntos
Autofagia , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Miocárdio/metabolismo , Animais , Apoptose/genética , Proteínas Reguladoras de Apoptose/genética , Proteínas Reguladoras de Apoptose/metabolismo , Proteínas Relacionadas à Autofagia , Proteína Beclina-1 , Western Blotting , Proteínas de Transporte/genética , Proteínas de Transporte/metabolismo , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/patologia , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/patologia , Cardiomiopatias Diabéticas/genética , Cardiomiopatias Diabéticas/metabolismo , Cardiomiopatias Diabéticas/patologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas Associadas aos Microtúbulos/genética , Proteínas Associadas aos Microtúbulos/metabolismo , Miocárdio/patologia , Espécies Reativas de Oxigênio/metabolismo , Proteínas rab de Ligação ao GTP/genética , Proteínas rab de Ligação ao GTP/metabolismo
8.
PLoS One ; 8(3): e59682, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23527250

RESUMO

Caloric restriction (CR) is a robust dietary intervention known to enhance cardiovascular health. AMP activated protein kinase (AMPK) has been suggested to mediate the cardioprotective effects of CR. However, this hypothesis remains to be tested by using definitive loss-of-function animal models. In the present study, we subjected AMPKα2 knockout (KO) mice and their wild type (WT) littermates to a CR regimen that reduces caloric intake by 20%-40% for 4 weeks. CR decreased body weight, heart weight and serum levels of insulin in both WT and KO mice to the same degree, indicating the effectiveness of the CR protocol. CR activated cardiac AMPK signaling in WT mice, but not in AMPKα2 KO mice. Correspondingly, AMPKα2 KO mice had markedly reduced cardiac function during CR as determined by echocardiography and hemodynamic measurements. The compromised cardiac function was associated with increased markers of oxidative stress, endoplasmic reticulum stress and myocyte apoptosis. Mechanistically, CR down-regulated the expression of ATP5g2, a subunit of mitochondrial ATP synthase, and reduced ATP content in AMPKα2 KO hearts, but not in WT hearts. In addition, CR accelerated cardiac autophagic flux in WT mice, but failed to do so in AMPKα2 KO mice. These results demonstrated that without AMPK, CR triggers adverse effects that can lead to cardiac dysfunction, suggesting that AMPK signaling pathway is indispensible for energy homeostasis and myocardial adaptation to CR, a dietary intervention that normally produces beneficial cardiac effects.


Assuntos
Proteínas Quinases Ativadas por AMP/metabolismo , Restrição Calórica , Coração/crescimento & desenvolvimento , Homeostase/fisiologia , Miocárdio/metabolismo , Transdução de Sinais/fisiologia , Proteínas Quinases Ativadas por AMP/genética , Trifosfato de Adenosina/metabolismo , Animais , Western Blotting , Peso Corporal , Estresse do Retículo Endoplasmático/fisiologia , Testes de Função Cardíaca , Marcação In Situ das Extremidades Cortadas , Insulina/sangue , Fator de Crescimento Insulin-Like I/metabolismo , Camundongos , Camundongos Knockout , Tamanho do Órgão , Estresse Oxidativo/fisiologia , Triglicerídeos/sangue
9.
Autophagy ; 8(4): 577-92, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22498478

RESUMO

Hyperglycemia is linked to increased heart failure among diabetic patients. However, the mechanisms that mediate hyperglycemia-induced cardiac damage remain poorly understood. Autophagy is a cellular degradation pathway that plays important roles in cellular homeostasis. Autophagic activity is altered in the diabetic heart, but its functional role has been unclear. In this study, we determined if mimicking hyperglycemia in cultured cardiomyocytes from neonatal rats and adult mice could affect autophagic activity and myocyte viability. High glucose (17 or 30 mM) reduced autophagic flux compared with normal glucose (5.5 mM) as indicated by the difference in protein levels of LC3-II (microtubule-associated protein 1 light chain 3 form II) or the changes of punctate fluorescence patterns of GFP-LC3 and mRFP-LC3 in the absence and presence of the lysosomal inhibitor bafilomycin A(1). Unexpectedly, the inhibited autophagy turned out to be an adaptive response that functioned to limit high glucose cardiotoxicity. Indeed, suppression of autophagy by 3-methyladenine or short hairpin RNA-mediated silencing of the Becn1 or Atg7 gene attenuated high glucose-induced cardiomyocyte death. Conversely, upregulation of autophagy with rapamycin or overexpression of Becn1 or Atg7 predisposed cardiomyocytes to high glucose toxicity. Mechanistically, the high glucose-induced inhibition of autophagy was mediated at least partly by increased mTOR signaling that likely inactivated ULK1 through phosphorylation at serine 467. Together, these findings demonstrate that high glucose inhibits autophagy, which is a beneficial adaptive response that protects cardiomyocytes against high glucose toxicity. Future studies are warranted to determine if autophagy plays a similar role in diabetic heart in vivo.


Assuntos
Autofagia/efeitos dos fármacos , Citoproteção/efeitos dos fármacos , Glucose/toxicidade , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/patologia , Adenina/análogos & derivados , Adenina/farmacologia , Animais , Animais Recém-Nascidos , Proteína 7 Relacionada à Autofagia , Cardiotônicos/metabolismo , Morte Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Canais de Potássio Éter-A-Go-Go/metabolismo , Técnicas de Silenciamento de Genes , Humanos , Lisossomos/efeitos dos fármacos , Lisossomos/metabolismo , Alvo Mecanístico do Complexo 1 de Rapamicina , Camundongos , Camundongos Endogâmicos C57BL , Complexos Multiproteicos , Miócitos Cardíacos/metabolismo , Fagossomos/efeitos dos fármacos , Fagossomos/metabolismo , Fosforilação/efeitos dos fármacos , Proteínas/metabolismo , Ratos , Transdução de Sinais/efeitos dos fármacos , Sirolimo/farmacologia , Serina-Treonina Quinases TOR , Enzimas Ativadoras de Ubiquitina/metabolismo
10.
J Pharmacol Exp Ther ; 341(1): 183-95, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22209892

RESUMO

Resveratrol is a plant-derived polyphenol that can attenuate the cardiotoxic effects of doxorubicin (DOX), a powerful antibiotic widely used in cancer chemotherapy. However, the underlying protective mechanisms of resveratrol remain elusive. Here, we show that resveratrol inhibited DOX-induced autophagy and cardiomyocyte death, and autophagy suppression is an important mechanism that mediates the ability of resveratrol to protect against DOX cardiotoxicity. Indeed, resveratrol, 3-methyladenine (3-MA), and a short hairpin RNA directed against autophagy gene beclin 1 (shBCN1) each was able to attenuate DOX-induced autophagy and cardiomyocyte death, but resveratrol did not provide additional protection in the presence of 3-MA or shBCN1. In contrast, up-regulation of autophagy by beclin 1 overexpression not only exacerbated DOX cardiotoxicity but also abolished the protective effects of resveratrol. Intriguingly, p70 S6 kinase 1 (S6K1) was activated by DOX, which was prevented by resveratrol. Knocking down S6K1 with small interfering RNA diminished DOX-induced autophagy and cardiotoxicity, but resveratrol failed to exert an additive effect. In addition, S6K1 overexpression impaired the ability of resveratrol to antagonize DOX-induced autophagy and cardiomyocyte death. Taken together, our data indicate that the protective effect of resveratrol against DOX cardiotoxicity largely depends on its ability to suppress DOX-induced autophagy via the inhibition of S6K1.


Assuntos
Autofagia/efeitos dos fármacos , Doxorrubicina/farmacologia , Miócitos Cardíacos/efeitos dos fármacos , Proteínas Quinases S6 Ribossômicas 70-kDa/antagonistas & inibidores , Proteínas Quinases S6 Ribossômicas 70-kDa/fisiologia , Estilbenos/farmacologia , Animais , Animais Recém-Nascidos , Autofagia/fisiologia , Morte Celular/efeitos dos fármacos , Morte Celular/fisiologia , Células Cultivadas , Doxorrubicina/antagonistas & inibidores , Miócitos Cardíacos/citologia , Miócitos Cardíacos/enzimologia , Ratos , Ratos Sprague-Dawley , Resveratrol
11.
J Biol Chem ; 286(25): 21993-2006, 2011 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-21521688

RESUMO

Caloric restriction (CR) is a dietary intervention known to enhance cardiovascular health. The glucose analog 2-deoxy-D-glucose (2-DG) mimics CR effects in several animal models. However, whether 2-DG is beneficial to the heart remains obscure. Here, we tested the ability of 2-DG to reduce cardiomyocyte death triggered by doxorubicin (DOX, 1 µm), an antitumor drug that can cause heart failure. Treatment of neonatal rat cardiomyocytes with 0.5 mm 2-DG dramatically suppressed DOX cytotoxicity as indicated by a decreased number of cells that stained positive for propidium iodide and reduced apoptotic markers. 2-DG decreased intracellular ATP levels by 17.9%, but it prevented DOX-induced severe depletion of ATP, which may contribute to 2-DG-mediated cytoprotection. Also, 2-DG increased the activity of AMP-activated protein kinase (AMPK). Blocking AMPK signaling with compound C or small interfering RNA-mediated knockdown of the catalytic subunit markedly attenuated the protective effects of 2-DG. Conversely, AMPK activation by pharmacological or genetic approach reduced DOX cardiotoxicity but did not produce additive effects when used together with 2-DG. In addition, 2-DG induced autophagy, a cellular degradation pathway whose activation could be either protective or detrimental depending on the context. Paradoxically, despite its ability to activate autophagy, 2-DG prevented DOX-induced detrimental autophagy. Together, these results suggest that the CR mimetic 2-DG can antagonize DOX-induced cardiomyocyte death, which is mediated through multiple mechanisms, including the preservation of ATP content, the activation of AMPK, and the inhibition of autophagy.


Assuntos
Restrição Calórica , Morte Celular/efeitos dos fármacos , Desoxiglucose/farmacologia , Doxorrubicina/efeitos adversos , Doxorrubicina/antagonistas & inibidores , Miócitos Cardíacos/citologia , Miócitos Cardíacos/efeitos dos fármacos , Proteínas Quinases Ativadas por AMP/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Autofagia/efeitos dos fármacos , Citoproteção/efeitos dos fármacos , Miócitos Cardíacos/enzimologia , Miócitos Cardíacos/metabolismo , Ratos , Ratos Sprague-Dawley
12.
J Biol Chem ; 285(1): 793-804, 2010 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-19901028

RESUMO

Doxorubicin (DOX) is a potent anti-tumor drug known to cause heart failure. The transcription factor GATA4 antagonizes DOX-induced cardiotoxicity. However, the protective mechanism remains obscure. Autophagy is the primary cellular pathway for lysosomal degradation of long-lived proteins and organelles, and its activation could be either protective or detrimental depending on specific pathophysiological conditions. Here we investigated the ability of GATA4 to inhibit autophagy as a potential mechanism underlying its protection against DOX toxicity in cultured neonatal rat cardiomyocytes. DOX markedly increased autophagic flux in cardiomyocytes as indicated by the difference in protein levels of LC3-II (microtubule-associated protein light chain 3 form 2) or numbers of autophagic vacuoles in the absence and presence of the lysosomal inhibitor bafilomycin A1. DOX-induced cardiomyocyte death determined by multiple assays was aggravated by a drug or genetic approach that activates autophagy, but it was attenuated by manipulations that inhibit autophagy, suggesting that autophagy contributes to DOX cardiotoxicity. DOX treatment depleted GATA4 protein levels, which predisposed cardiomyocytes to DOX toxicity. Indeed, GATA4 gene silencing triggered autophagy that rendered DOX more toxic, whereas GATA4 overexpression inhibited DOX-induced autophagy, reducing cardiomyocyte death. Mechanistically, GATA4 up-regulated gene expression of the survival factor Bcl2 and suppressed DOX-induced activation of autophagy-related genes, which may likely be responsible for the anti-apoptotic and anti-autophagic effects of GATA4. Together, these findings suggest that activation of autophagy mediates DOX cardiotoxicity, and preservation of GATA4 attenuates DOX cardiotoxicity by inhibiting autophagy through modulation of the expression of Bcl2 and autophagy-related genes.


Assuntos
Apoptose/efeitos dos fármacos , Autofagia/efeitos dos fármacos , Doxorrubicina/farmacologia , Fator de Transcrição GATA4/metabolismo , Miócitos Cardíacos/citologia , Miócitos Cardíacos/efeitos dos fármacos , Adenina/análogos & derivados , Adenina/farmacologia , Animais , Proteínas Reguladoras de Apoptose/metabolismo , Autofagia/genética , Proteína Beclina-1 , Fator de Transcrição GATA4/deficiência , Fator de Transcrição GATA4/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Técnicas de Silenciamento de Genes , Proteínas Associadas aos Microtúbulos/metabolismo , Miócitos Cardíacos/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , RNA Interferente Pequeno/metabolismo , Ratos , Ratos Sprague-Dawley , Sirolimo/farmacologia
13.
Artigo em Chinês | MEDLINE | ID: mdl-18322592

RESUMO

OBJECTIVE: To construct eukaryotic expression plasmid IRES-gD-IL-2 which contains both HSV-1 glycoprotein D (gD) gene and IL-2 gene and to induce it to express in antigen presenting cell (APC) -- dendritic cells (DCs). METHODS: The whole sequence of gD and IL-2 were amplified by PCR assay. After confirmation by PCR, double-enzyme digestion and sequencing, these genes were directly cloned into eukaryotic expression vector IRES, then were transfected into DCs. Western blotting was employed to identify the transcription and expression of gD gene. RESULTS: The results of PCR and enzyme digestion showed that the recombinant expression plasmid contained correct fragments, and the transcription and expression of gD were confirmed by Western blotting. CONCLUSION: The recombinant expression vector IRES-gD-IL-2 was constructed, the results of the Western blotting showed that the recombinant protein could be identified by gD- specific antibody, therefore the protein has immunologic competence.


Assuntos
Células Dendríticas/metabolismo , Interleucina-2/genética , Proteínas Recombinantes de Fusão/genética , Proteínas do Envelope Viral/genética , Western Blotting , Vacinas contra o Vírus do Herpes Simples/imunologia , Humanos , Plasmídeos , Proteínas Recombinantes de Fusão/imunologia , Vacinas de DNA/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...